Aquis Exchange recommences trading in Swiss shares

February 4, 2021

Aquis Exchange PLC

(“Aquis” or the “Company”)

Aquis Exchange recommences trading in Swiss shares

Aquis Exchange PLC (AQX.L), the exchange services group, is pleased to announce the resumption of trading in Swiss shares on its pan-European exchange facility, Aquis Exchange.

Following the UK government’s agreement on equivalence with Switzerland, UK-based exchanges now have the ability to offer trading in Swiss shares. This follows the ban on EU venues from offering trading in Swiss shares, implemented in July 2019 after the EU did not renew equivalence with Switzerland.

The shares will be traded on Aquis Exchange’s London venue, and include over 125 key Swiss names including Novartis, Roche and Nestlé.  

Alasdair Haynes, CEO of Aquis Exchange, said:

“We’re pleased to once again be able to offer the trading of Swiss shares to our clients.

Jointly through our London and Paris venues Aquis Exchange now covers 15 markets, with our clients continuing to benefit from our unique subscription pricing model, fast technology and deep liquidity on the Exchange.”

- Ends -

Enquiries:

Aquis Exchange PLC

Tel: +44 (0) 20 3597 6321

Alasdair Haynes, CEO

 

Jonathan Clelland, CFO and COO

 

Belinda Keheyan, Head of Marketing

+44 (0) 7768 078 110

   

Liberum Capital Limited (Nominated Adviser and Joint Broker)

Tel: +44 (0) 20 3100 2000

Clayton Bush

 

Chris Clarke

 

Edward Thomas

 

Kane Collings

 

 

 

Canaccord Genuity Limited (Joint Broker)

Tel: +44 (0) 20 7523 8000

Emma Gabriel (Corporate Broking)

Jeremy Grime (Specialist Sales)

 

 

 

Alma PR (Financial PR Adviser)

Tel: +44 (0)20 3405 0209

Susie Hudson

Rebecca Sanders-Hewett

aquis@almapr.co.uk

Kieran Breheny

Faye Calow

 

 

Notes to editors:

Aquis Exchange PLC is an exchange services group, which operates pan-European cash equities trading businesses (Aquis Exchange), growth and regulated primary markets (Aquis Stock Exchange/AQSE) and develops/licenses exchange software to third parties (Aquis Technologies).

Aquis Exchange is authorised and regulated by the UK Financial Conduct Authority and France's Autorité des Marchés Financiers to operate Multilateral Trading Facility businesses in the UK and in the EU27 respectively. Aquis operates a lit order book and does not allow aggressive non-client proprietary trading, which has resulted in lower market impact and signalling risk on Aquis than other trading venues in Europe. According to independent studies, trades on Aquis are less likely to lead to price movement than on other lit markets. Aquis uses a subscription pricing model which works by charging users according to the message traffic they generate, rather than a percentage of the value of each stock that they trade.

Aquis Stock Exchange (AQSE) is a stock market providing primary and secondary markets for equity and debt products. It is authorised as a Recognised Investment Exchange, which allows it to operate a regulated listings venue.

Aquis Technologies is the software and technology division of Aquis Exchange PLC. It creates and licenses cutting-edge, cost-effective matching engine and trade surveillance technology for banks, brokers, investment firms and exchanges.

Aquis Exchange PLC (AQX.L) is listed on the Alternative Investment Market of the LSE (AIM) market. For more information, please go to www.aquis.eu